(KDA) KDA - Ratings and Ratios
Exchange: V • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA48669F1071
KDA: Prescription Platforms, Virtual Resources, Clinical Management, Patient Portals
KDA Group Inc., together with its subsidiaries, provides technological solutions to general and specialized health sectors in Canada. It offers Prescripteur KRx, an electronic prescription platform assisting dentists in practice; KRx Cannabinoid, an electronic prescription platform helping doctors in practice for prescribing medical cannabis; Adherize (ADRX), a suite of virtual resources to present and share crucial information for doctors and pharmacists, as well as a patient portal allows easy access to personalized information; and Medherize, a platform for clinical management of patients requiring specialized medication. The company was formerly known as AlliancePharma Inc. and changed its name to KDA Group Inc. in February 2017. KDA Group Inc. is headquartered in Thetford Mines, Canada. Web URL: https://groupekda.ca
Additional Sources for KDA Stock
KDA Stock Overview
| Market Cap in USD | 33m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception |
KDA Stock Ratings
| Growth 5y | 1.92% |
| Fundamental | - |
| Dividend | - |
| Rel. Strength Industry | -42.6 |
| Analysts | - |
| Fair Price Momentum | 0.25 CAD |
| Fair Price DCF | - |
KDA Dividends
No Dividends PaidKDA Growth Ratios
| Growth Correlation 3m | 65.2% |
| Growth Correlation 12m | -53.2% |
| Growth Correlation 5y | 13.8% |
| CAGR 5y | 3.33% |
| CAGR/Mean DD 5y | 0.08 |
| Sharpe Ratio 12m | 0.36 |
| Alpha | -19.34 |
| Beta | 0.60 |
| Volatility | 183.13% |
| Current Volume | 55.5k |
| Average Volume 20d | 65.6k |
What is the price of KDA stocks?
As of January 22, 2025, the stock is trading at CAD 0.27 with a total of 55,500 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -8.62%, over three months by -1.85% and over the past year by +1.92%.
As of January 22, 2025, the stock is trading at CAD 0.27 with a total of 55,500 shares traded.
Over the past week, the price has changed by +0.00%, over one month by -8.62%, over three months by -1.85% and over the past year by +1.92%.
Is KDA a good stock to buy?
Neither. Based on ValueRay Analyses, KDA is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.92 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KDA as of January 2025 is 0.25. This means that KDA is currently overvalued and has a potential downside of -7.41%.
Neither. Based on ValueRay Analyses, KDA is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.92 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of KDA as of January 2025 is 0.25. This means that KDA is currently overvalued and has a potential downside of -7.41%.
Is KDA a buy, sell or hold?
KDA has no consensus analysts rating.
KDA has no consensus analysts rating.
What are the forecast for KDA stock price target?
According to ValueRays Forecast Model, KDA KDA will be worth about 0.3 in January 2026. The stock is currently trading at 0.27. This means that the stock has a potential upside of +0%.
According to ValueRays Forecast Model, KDA KDA will be worth about 0.3 in January 2026. The stock is currently trading at 0.27. This means that the stock has a potential upside of +0%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.3 | 0% |